Becton Dickinson & Co. (BDX): Price and Financial Metrics


Becton Dickinson & Co. (BDX): $251.80

5.27 (+2.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BDX POWR Grades


  • BDX scores best on the Stability dimension, with a Stability rank ahead of 86.22% of US stocks.
  • BDX's strongest trending metric is Value; it's been moving down over the last 179 days.
  • BDX's current lowest rank is in the Momentum metric (where it is better than 19.56% of US stocks).

BDX Stock Summary

  • BDX has a market capitalization of $76,822,693,442 -- more than approximately 96.6% of US stocks.
  • Becton Dickinson & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
  • The volatility of Becton Dickinson & Co's share price is greater than that of only 4.16% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to BDX, based on their financial statements, market capitalization, and price volatility, are ATRI, SYNA, PLXS, ADTN, and O.
  • Visit BDX's SEC page to see the company's official filings. To visit the company's web site, go to www.bd.com.

BDX Valuation Summary

  • BDX's price/sales ratio is 3.6; this is 68.28% lower than that of the median Healthcare stock.
  • BDX's price/sales ratio has moved up 1.1 over the prior 243 months.
  • BDX's price/earnings ratio has moved up 15.2 over the prior 243 months.

Below are key valuation metrics over time for BDX.

Stock Date P/S P/B P/E EV/EBIT
BDX 2021-08-31 3.6 3.0 38.8 33.3
BDX 2021-08-30 3.6 3.0 38.6 33.2
BDX 2021-08-27 3.6 3.0 38.3 33.0
BDX 2021-08-26 3.6 2.9 38.1 32.9
BDX 2021-08-25 3.6 2.9 38.0 32.8
BDX 2021-08-24 3.6 2.9 38.2 32.9

BDX Growth Metrics

    Its 3 year revenue growth rate is now at 39.25%.
  • Its 4 year price growth rate is now at 55.45%.
  • The 5 year net cashflow from operations growth rate now stands at 56.48%.
BDX's revenue has moved up $2,810,000,000 over the prior 15 months.

The table below shows BDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 19,927 3,788 1,676
2021-09-30 20,248 4,647 2,002
2021-06-30 19,896 5,177 1,865
2021-03-31 18,861 5,064 1,640
2020-12-31 18,207 4,359 1,508
2020-09-30 17,117 3,539 767

BDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BDX has a Quality Grade of C, ranking ahead of 56.62% of graded US stocks.
  • BDX's asset turnover comes in at 0.365 -- ranking 118th of 186 Medical Equipment stocks.
  • MYO, BTCY, and NURO are the stocks whose asset turnover ratios are most correlated with BDX.

The table below shows BDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.365 0.470 0.103
2021-03-31 0.347 0.469 0.092
2020-12-31 0.337 0.458 0.088
2020-09-30 0.321 0.443 0.059
2020-06-30 0.320 0.451 0.053
2020-03-31 0.333 0.462 0.062

BDX Price Target

For more insight on analysts targets of BDX, see our BDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $267.80 Average Broker Recommendation 1.58 (Moderate Buy)

BDX Stock Price Chart Interactive Chart >

Price chart for BDX

BDX Price/Volume Stats

Current price $251.80 52-week high $280.62
Prev. close $246.53 52-week low $231.46
Day low $244.32 Volume 774,900
Day high $252.17 Avg. volume 1,269,251
50-day MA $250.36 Dividend yield 1.38%
200-day MA $254.40 Market Cap 71.78B

Becton Dickinson & Co. (BDX) Company Bio


Becton, Dickinson and Company provides solutions which are focused on improving medication management and patient safety, supporting infection prevention practices, equipping surgical and interventional procedures, improving drug delivery, aiding anesthesiology and respiratory care, advancing cellular research and applications, enhancing the diagnosis of infectious diseases and cancers, and supporting the management of diabetes. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.


BDX Latest News Stream


Event/Time News Detail
Loading, please wait...

BDX Latest Social Stream


Loading social stream, please wait...

View Full BDX Social Stream

Latest BDX News From Around the Web

Below are the latest news stories about Becton Dickinson & Co that investors may wish to consider to help them evaluate BDX as an investment opportunity.

BD to Present at the Cowen 42nd Annual Health Care Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will virtually present at the Cowen 42nd Annual Health Care Conference via webcast. BD's management is scheduled to present on Monday, March 7, 2022 at 9:50 a.m. Eastern Time.

Yahoo | February 24, 2022

Becton Dickinson (BDX) Crossed Above the 20-Day Moving Average: What That Means for Investors

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Yahoo | February 24, 2022

If You Invested $1000 in Becton Dickinson 10 Years Ago, This Is How Much You'd Have Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Yahoo | February 24, 2022

BD Appoints Shana Neal as Chief People Officer

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shana Neal has been appointed chief people officer, effective April 4, 2022.

Yahoo | February 23, 2022

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.

Yahoo | February 23, 2022

Read More 'BDX' Stories Here

BDX Price Returns

1-mo -0.41%
3-mo -3.75%
6-mo 2.68%
1-year 5.36%
3-year 5.29%
5-year 41.74%
YTD 3.39%
2021 1.88%
2020 -6.75%
2019 22.20%
2018 6.61%
2017 31.24%

BDX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BDX Dividend History

Continue Researching BDX

Here are a few links from around the web to help you further your research on Becton Dickinson & Co's stock as an investment opportunity:

Becton Dickinson & Co (BDX) Stock Price | Nasdaq
Becton Dickinson & Co (BDX) Stock Quote, History and News - Yahoo Finance
Becton Dickinson & Co (BDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4712 seconds.